Bausch Health Companies Inc. (BHC): R&D Expense
$629.00M
Year ended 2025-12-31
$663.00M
Trailing 12 months to 2026-06-30
+5.9%
3-year compound annual growth
+6.8%
5-year compound annual growth
+6.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $629.00M | +2.1% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $616.00M | +2.0% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $604.00M | +14.2% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $529.00M | +13.8% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $465.00M | +2.9% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $452.00M | -4.0% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $471.00M | +14.0% | 2022-02-23, From 2019-01-01 |
| 2018-12-31 | $413.00M | +14.4% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $361.00M | -14.3% | 2020-02-19, From 2017-01-01 |
| 2016-12-31 | $421.00M | +26.0% | 2019-02-20, From 2016-01-01 |
| 2015-12-31 | $334.00M | +35.8% | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | $246.00M | +56.9% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $156.80M | +98.2% | 2016-04-29, From 2013-01-01 |
| 2012-12-31 | $79.10M | +20.4% | 2015-02-25, From 2012-01-01 |
| 2011-12-31 | $65.69M | -3.8% | 2014-02-28, From 2011-01-01 |
| 2010-12-31 | $68.31M | +43.6% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $47.58M | -31.8% | 2012-02-29, From 2009-01-01 |
| 2008-12-31 | $69.81M | n/a | 2011-02-28, From 2008-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $629.00M | +2.1% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $698.00M | +1.7% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.91B | +7.7% |
| Viatris Inc (VTRS) | 2025-12-31 | $965.90M | +19.4% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $5.85B | +14.0% |
| Organon & Co. (OGN) | 2025-12-31 | $366.00M | -22.0% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.01B | +1.5% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $2.15B | +9.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $368.00M | +7.0% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗